Effect of antiplatelet therapy on acute respiratory distress syndrome and mortality in critically ill patients: A meta-analysis

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Wang, Lijun ^a   Li, Heng ^a   Gu, Xiaofei ^a   Wang, Zhen ^a   Liu, Su ^a   Chen, Liyong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANAGRELIDE; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; CLOPIDOGREL; DIPYRIDAMOLE; TICLOPIDINE;

ACUTE LUNG INJURY; ARTICLE; COHORT ANALYSIS; CRITICALLY ILL PATIENT; DRUG ACTIVITY; DRUG EFFECT; EFFECT SIZE; HOSPITALIZATION; HUMAN; INCIDENCE; MORTALITY; NEWCASTLE OTTAWA SCALE; PUBLISHING; QUANTITATIVE ANALYSIS; RANDOM SAMPLE; RATING SCALE; RESPIRATORY DISTRESS; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY ANALYSIS; SEPSIS; SEPTIC SHOCK; SYSTEMATIC REVIEW; COMORBIDITY; CRITICAL ILLNESS; META ANALYSIS; ODDS RATIO; RESPIRATORY DISTRESS SYNDROME, ADULT;

COHORT STUDIES; COMORBIDITY; CRITICAL ILLNESS; HUMANS; INCIDENCE; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; PUBLICATION BIAS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84969514545     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154754     Document Type: Article

References (49)

1. Stoller J, Halpin L, Weis M, Aplin B, Qu W, Georgescu C, et al. Epidemiology of severe sepsis: 2008-2012. J Crit Care. 2016; 31: 58-62. doi: 10.1016/j.jcrc.2015.09.034 PMID: 26601855
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29: 1303-10. PMID: 11445675
3. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005; 353: 1685-93. PMID: 16236739
4. McAuley DF, Laffey JG, O'Kane CM, Perkins GD, Mullan B, Trinder TJ, et al. Simvastatin in the acute respiratory distress syndrome. N Engl J Med. 2014; 371: 1695-703. doi: 10.1056/NEJMoa1403285 PMID: 25268516
5. Yadav H, Kor DJ. Platelets in the pathogenesis of acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol. 2015; 309: L915-L923. doi: 10.1152/ajplung.00266.2015 PMID: 26320157
6. Katz JN, Kolappa KP, Becker RC. Beyond thrombosis: the versatile platelet in critical illness. Chest. 2011; 139: 658-668. doi: 10.1378/chest.10-1971 PMID: 21362652
7. Semple JW, Italiano JJ, Freedman J. Platelets and the immune continuum. Nat Rev Immunol. 2011; 11: 264-274. doi: 10.1038/nri2956 PMID: 21436837
8. Vandijck DM, Blot SI, De Waele JJ, Hoste EA, Vandewoude KH, Decruyenaere JM. Thrombocytopenia and outcome in critically ill patients with bloodstream infection. Heart Lung. 2010; 39: 21-26. doi: 10. 1016/j.hrtlng.2009.07.005 PMID: 20109983
9. Wu Q, Ren J, Wang G, Li G, Anjum N, Hu D, et al. Effect of Persistent Thrombocytopenia on Mortality in Surgical Critical Care Patients: A Retrospective Study. Clin Appl Thromb Hemost. 2015.
10. Moreau D, Timsit JF, Vesin A, Garrouste-Orgeas M, de Lassence A, Zahar JR, et al. Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays. Chest. 2007; 131: 1735-1741. PMID: 17475637
11. Tsai MJ, Ou SM, Shih CJ, Chao PW, Wang LF, Shih YN, et al. Association of prior antiplatelet agents with mortality in sepsis patients: a nationwide population-based cohort study. Intensive Care Med. 2015; 41: 806-813. doi: 10.1007/s00134-015-3760-y PMID: 25829229
12. Boyle AJ, Di Gangi S, Hamid UI, Mottram LJ, McNamee L, White G, et al. Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis. Crit Care. 2015; 19: 109. doi: 10.1186/s13054-015-0846-4 PMID: 25887566
13. Winning J, Neumann J, Kohl M, Claus RA, Reinhart K, Bauer M, et al. Antiplatelet drugs and outcome in mixed admissions to an intensive care unit. Crit Care Med. 2010; 38: 32-37. doi: 10.1097/CCM. 0b013e3181b4275c PMID: 19770746
14. Valerio-Rojas JC, Jaffer IJ, Kor DJ, Gajic O, Cartin-Ceba R. Outcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment: a historical cohort study. Crit Care Res Pract. 2013; 2013: 782573. doi: 10.1155/2013/782573 PMID: 23509620
15. Chen W, Janz DR, Bastarache JA, May AK, O'Neal HJ, Bernard GR, et al. Prehospital aspirin use is associated with reduced risk of acute respiratory distress syndrome in critically ill patients: a propensity-adjusted analysis. Crit Care Med. 2015; 43: 801-807. doi: 10.1097/CCM.0000000000000789 PMID: 25559436
16. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. Ann Intern Med. 2009; 151: 264-269, W64. PMID: 19622511
17. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25: 603-605. doi: 10.1007/s10654-010-9491-z PMID: 20652370
18. Davies HT, Crombie IK, Tavakoli M. When can odds ratios mislead? BMJ. 1998; 316: 989-991. PMID: 9550961
19. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315: 629-634. PMID: 9310563
20. Otto GP, Sossdorf M, Boettel J, Kabisch B, Breuel H, Winning J, et al. Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock. Platelets. 2013; 24: 480-485. doi: 10.3109/09537104.2012.724482 PMID: 22994591
21. Eisen DP, Reid D, McBryde ES. Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis. Crit Care Med. 2012; 40: 1761-1767. doi: 10. 1097/CCM.0b013e318246b9df PMID: 22610182
22. Kor DJ, Erlich J, Gong MN, Malinchoc M, Carter RE, Gajic O, et al. Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients. Crit Care Med. 2011; 39: 2393-2400. doi: 10.1097/CCM.0b013e318225757f PMID: 21725238
23. Erlich JM, Talmor DS, Cartin-Ceba R, Gajic O, Kor DJ. Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study. Chest. 2011; 139: 289-295. doi: 10.1378/chest.10-0891 PMID: 20688925
24. Chalmers JD, Singanayagam A, Murray MP, Hill AT. Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med. 2008; 121: 1002-1007. doi: 10.1016/j.amjmed. 2008.06.030 PMID: 18954848
25. Mazzeffi M, Kassa W, Gammie J, Tanaka K, Roman P, Zhan M, et al. Preoperative Aspirin Use and Lung Injury After Aortic Valve Replacement Surgery: A Retrospective Cohort Study. Anesth Analg. 2015; 121: 271-277. doi: 10.1213/ANE.0000000000000793 PMID: 25993389
26. Falcone M, Russo A, Cangemi R, Farcomeni A, Calvieri C, Barilla F, et al. Lower mortality rate in elderly patients with community-onset pneumonia on treatment with aspirin. J Am Heart Assoc. 2015; 4: e1595.
27. Harr JN, Moore EE, Johnson J, Chin TL, Wohlauer MV, Maier R, et al. Antiplatelet therapy is associated with decreased transfusion-associated risk of lung dysfunction, multiple organ failure, and mortality in trauma patients. Crit Care Med. 2013; 41: 399-404. doi: 10.1097/CCM.0b013e31826ab38b PMID: 23263579
28. O'Neal HJ, Koyama T, Koehler EA, Siew E, Curtis BR, Fremont RD, et al. Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome. Crit Care Med. 2011; 39: 1343-1350. doi: 10.1097/CCM.0b013e3182120992 PMID: 21336116
29. Gross AK, Dunn SP, Feola DJ, Martin CA, Charnigo R, Li Z, et al. Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness. J Thromb Thrombolysis. 2013; 35: 147-154. doi: 10.1007/ s11239-012-0833-4 PMID: 23124575
30. Kor DJ, Talmor DS, Banner-Goodspeed VM, Carter RE, Hinds R, Park PK, et al. Lung Injury Prevention with Aspirin (LIPS-A): a protocol for a multicentre randomised clinical trial in medical patients at high risk of acute lung injury. BMJ Open. 2012; 2.
31. Ahmed AH, Litell JM, Malinchoc M, Kashyap R, Schiller HJ, Pannu SR, et al. The role of potentially preventable hospital exposures in the development of acute respiratory distress syndrome: a populationbased study. Crit Care Med. 2014; 42: 31-39. doi: 10.1097/CCM.0b013e318298a6db PMID: 23982022
32. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994; 149: 818-824. PMID: 7509706
33. Gando S. Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med. 2010; 38: S35-S42. doi: 10.1097/CCM.0b013e3181c9e31d PMID: 20083912
34. Winning J, Reichel J, Eisenhut Y, Hamacher J, Kohl M, Deigner HP, et al. Anti-platelet drugs and outcome in severe infection: clinical impact and underlying mechanisms. Platelets. 2009; 20: 50-57. doi: 10.1080/09537100802503368 PMID: 19172522
35. Alhazzani W, Lim W, Jaeschke RZ, Murad MH, Cade J, Cook DJ. Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med. 2013; 41: 2088-2098. doi: 10.1097/CCM.0b013e31828cf104 PMID: 23782973
36. Zarychanski R, Abou-Setta AM, Kanji S, Turgeon AF, Kumar A, Houston DS, et al. The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. Crit Care Med. 2015; 43: 511-518. doi: 10.1097/CCM.0000000000000763 PMID: 25493972
37. Afshari A, Wetterslev J, Brok J, Moller A. Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis. BMJ. 2007; 335: 1248-1251. PMID: 18037615
38. Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, et al. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA. 2003; 290: 238-247. PMID: 12851279
39. Thomas MR, Storey RF. The role of platelets in inflammation. Thromb Haemost. 2015; 114: 449-458. doi: 10.1160/TH14-12-1067 PMID: 26293514
40. Semple JW, Italiano JJ, Freedman J. Platelets and the immune continuum. Nat Rev Immunol. 2011; 11: 264-274. doi: 10.1038/nri2956 PMID: 21436837
41. Aronoff DM. Cyclooxygenase inhibition in sepsis: is there life after death? Mediators Inflamm. 2012; 2012: 696897. doi: 10.1155/2012/696897 PMID: 22665954
42. Arons MM, Wheeler AP, Bernard GR, Christman BW, Russell JA, Schein R, et al. Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med. 1999; 27: 699-707. PMID: 10321658
43. Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med. 1997; 336: 912-918. PMID: 9070471
44. Williams AE, Chambers RC. The mercurial nature of neutrophils: still an enigma in ARDS? Am J Physiol Lung Cell Mol Physiol. 2014; 306: L217-L230. doi: 10.1152/ajplung.00311.2013 PMID: 24318116
45. Zarbock A, Singbartl K, Ley K. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest. 2006; 116: 3211-3219. PMID: 17143330
46. Matute-Bello G, Liles WC, Radella FN, Steinberg KP, Ruzinski JT, Jonas M, et al. Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1997; 156: 1969-1977. PMID: 9412582
47. El KD, Jozsef L, Pan W, Wang L, Petasis NA, Serhan CN, et al. 15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury. Am J Respir Crit Care Med. 2009; 180: 311-319. doi: 10.1164/rccm.200810-1601OC PMID: 19483113
48. Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, Pike F, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014; 370: 1683-1693. doi: 10.1056/ NEJMoa1401602 PMID: 24635773
49. Boyle AJ, McNamee JJ, McAuley DF. Biological therapies in the acute respiratory distress syndrome. Expert Opin Biol Ther. 2014; 14: 969-981. doi: 10.1517/14712598.2014.905536 PMID: 24702248